Clinical Trial Update: Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin

View source ↗

Summary

This terminated clinical trial compared higher-dose or extended-duration enoxaparin versus conventional dosing for venous thromboembolism prophylaxis in obese p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Sanofi | Conditions: Venous Thromboembolism | Status: TERMINATED